Identification of stage IIA melanoma patients at high risk for disease relapse using a clinicopathologic and gene expression model.

e22088Background: In recent years, adjuvant therapy trials in stage III melanoma have been successful and trials have started with the inclusion of stage IIB/C patients. However, stage IIA melanoma...